DRUG

mesalazine

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for mesalazine

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR pancreatic ductal adenocarcinoma 0.208 Mid novel signal none

Clinical trials

200 registered trials for mesalazine

Source: ClinicalTrials.gov

← All drugs